Filed Pursuant to Rule 424(b)(3)

Registration No. 333-258963

 

PROSPECTUS SUPPLEMENT NO. 1
(to prospectus dated August 30, 2021)

 

REE AUTOMOTIVE LTD.

 

39,041,351 Class A Ordinary Shares
5,500,000 Warrants to Purchase Class A Ordinary Shares
15,562,500 Class A Ordinary Shares Underlying Warrants

 

This prospectus supplement amends and supplements the prospectus dated August 30, 2021 (the “Prospectus”) which forms a part of our Registration Statement on Form F-1, as amended and supplemented (Registration Statement No. 333-258963). This prospectus supplement is being filed to update and supplement the information included in the Prospectus with the GAAP financial statements tables contained in our report of foreign private issuer on Form 6-K, furnished to the Securities and Exchange Commission (the “SEC”) on November 16, 2021 (the “Form 6-K”). Such tables from the Form 6-K are attached to this prospectus supplement.

 

This prospectus supplement updates and supplements the information in the Prospectus and is not complete without, and may not be delivered or utilized except in combination with, the Prospectus, including any amendments or supplements thereto. This prospectus supplement should be read in conjunction with the Prospectus and if there is any inconsistency between the information in the Prospectus and this prospectus supplement, you should rely on the information in this prospectus supplement.

 

Our Class A ordinary shares, without par value (“Class A Ordinary Shares”), and warrants to purchase Class A Ordinary Shares (“Warrants”) are traded on The Nasdaq Global Market (“Nasdaq”) under the symbols “REE” and “REEAW,” respectively. The last reported sale price of the Ordinary Shares on November 15, 2021 was $4.19 per share, and the last reported sale price of the Warrants on November 15, 2021 was $0.808 per warrant, as reported on Nasdaq.

 

You should read the Prospectus and any prospectus supplement or amendment carefully before you invest in our securities. Investing in the Company’s securities involves risks. See “Risk Factors” beginning on page 10 of the Prospectus.

 

Neither the SEC nor any state securities commission has approved or disapproved of the securities to be issued under the Prospectus or passed upon the adequacy or accuracy of the Prospectus or this prospectus supplement. Any representation to the contrary is a criminal offense.

 

The date of this prospectus supplement is November 16, 2021.

 

 

 

REE AUTOMOTIVE LTD.

Condensed Consolidated Statements of Operations

U.S. dollars in thousands (except share and per share data)

(Unaudited)

 

   Three Months Ended   Nine Months Ended 
   September 30,   June 30,   September 30,   September 30,   September 30, 
   2021   2021   2020   2021   2020 
Revenues   -    -    119    6    336 
Cost of sales   324    4    224    339    569 
Gross loss   (324)   (4)   (105)   (333)   (233)
Operating expenses:                         
Research and development expenses, net   212,438    9,545    4,465    229,132    24,618 
Selling, general and administrative expenses   219,507    21,590    14,301    246,545    32,520 
Total operating expenses   431,945    31,135    18,766    475,677    57,138 
Operating loss   (432,269)   (31,139)   (18,871)   (476,010)   (57,371)
Income from warrant revaluation   17,263    -    -    17,263    - 
Financial income, net   114    8    84    126    377 
Net loss before income tax   (414,892)   (31,131)   (18,787)   (458,621)   (56,994)
Income tax expense   13    45    -    58    - 
Net loss   (414,905)   (31,176)   (18,787)   (458,679)   (56,994)
Net comprehensive loss   (414,905)   (31,176)   (18,787)   (458,679)   (56,994)
Basic and diluted net loss per share   (1.57)   (0.16)   (0.12)   (2.09)   (0.37)
Weighted average number of ordinary shares and preferred shares used in computing basic and diluted net loss per share   264,141,657    198,999,979    159,596,841    219,207,053    152,393,020 

 

2

 

REE AUTOMOTIVE LTD.

CONDENSED CONSOLIDATED BALANCE SHEETS

U.S. dollars in thousands (except share and per share data)

 

   September 30,   December 31, 
   2021   2020 
   Unaudited   Audited 
ASSETS        
         
CURRENT ASSETS:        
Cash and cash equivalents  $294,489   $44,707 
Restricted cash   1,074    800 
Short-term deposits   -    1,667 
Inventory   253    271 
Trade receivables   1    55 
Other receivables and prepaid expenses   10,612    428 
Total current assets   306,429    47,928 
           
NON-CURRENT ASSETS:          
Deferred transaction costs   -    328 
Property and equipment, net   1,921    755 
Total non-current assets   1,921    1,083 
           
TOTAL ASSETS  $308,350   $49,011 
           
LIABILITIES AND SHAREHOLDERS’ EQUITY          
           
CURRENT LIABILITIES:          
Trade payables  $3,399   $970 
Other payables and accrued expenses   7,358    2,260 
Deferred revenues   578    - 
Total current liabilities   11,335    3,230 
           
NON-CURRENT LIABILITIES:          
Warrants liability   14,795    - 
Total non-current liabilities   14,795    - 
           
TOTAL LIABILITIES   26,130    3,230 
           
SHAREHOLDERS’ EQUITY:          
Ordinary and Preferred shares(1)   -    - 
Additional paid-in capital   850,077    154,959 
Accumulated deficit   (567,857)   (109,178)
Total shareholders’ equity   282,220    45,781 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY  $308,350   $49,011 

 

(1)Shares and per share data are presented on a retroactive basis to reflect the stock split following completion of the Merger on July 22, 2021.

 

3

 

REE AUTOMOTIVE LTD.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW

U.S. dollars in thousands

(Unaudited)

 

   Nine Months Ended
September 30,
 
   2021   2020 
Cash flows from operating activities:        
Net loss   (458,679)   (56,994)
Adjustments required to reconcile net loss to net cash used in operating activities:          
Depreciation   292    115 
Capital loss   92    18 
Share-based compensation   433,962    48,039 
Revaluation of warrants liability   (17,263)   - 
Transaction costs related to warrants   2,887    - 
Decrease in inventory   18    49 
Decrease (increase) in trade receivables   54    (61)
Increase in other receivables and prepaid expenses   (10,124)   (343)
Increase in trade payables   2,635    866 
Increase in other payables and accrued expenses   4,879    767 
Deferred revenues   578    - 
Net cash used in operating activities   (40,669)   (7,544)
           
Cash flows from investing activities:          
           
Proceeds from deposits   1,667    - 
Purchase of property and equipment   (1,428)   (510)
Net cash provided by (used in) investing activities   239    (510)
           
Cash flows from financing activities:          
           
Proceeds from exercise of warrants to preferred shares   2,907    - 
Proceeds from merger, net of transaction costs   287,579    - 
Proceeds from exercise of ordinary shares   -    209 
Proceeds from issuance of Preferred shares, net   -    25,825 
Net cash provided by financing activities   290,486    26,034 
           
Increase in cash, cash equivalents and restricted cash   250,056    17,980 
Cash, cash equivalents and restricted cash at beginning of year   45,507    27,712 
Cash, cash equivalents and restricted cash at end of period  $295,563   $45,692 

 

 

4